BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Weinhandl ED, Peng Y, Gilbertson DT, Bradbury BD, Collins AJ. Hemoglobin variability and mortality: confounding by disease severity. Am J Kidney Dis 2011;57:255-65. [PMID: 20801571 DOI: 10.1053/j.ajkd.2010.06.013] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
Number Citing Articles
1 Gupta AK, David W. Does erythropoietin cause hemoglobin variability--is it 'normal'? PLoS One 2014;9:e92890. [PMID: 24709756 DOI: 10.1371/journal.pone.0092890] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
2 Wish JB. Hemoglobin variability as a predictor of mortality: What's a practitioner to do? Am J Kidney Dis 2011;57:190-3. [PMID: 21251539 DOI: 10.1053/j.ajkd.2010.11.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Thakuria M, Ofsthun NJ, Mullon C, Diaz-Buxo JA. Anemia management in patients receiving chronic hemodialysis. Semin Dial 2011;24:597-602. [PMID: 21999745 DOI: 10.1111/j.1525-139X.2011.00975.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
4 Ganidagli SE, Altunoren O, Erken E, Isık IO, Ganidagli B, Eren N, Yavuz YC, Gungor O. The relation between hemoglobin variability and carotid intima-media thickness in chronic hemodialysis patients. Int Urol Nephrol 2017;49:1859-66. [PMID: 28711962 DOI: 10.1007/s11255-017-1651-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
5 Gilbertson DT, Hu Y, Peng Y, Maroni BJ, Wetmore JB. Variability in hemoglobin levels in hemodialysis patients in the current era: a retrospective cohort study. Clin Nephrol 2017;88:254-65. [PMID: 28899480 DOI: 10.5414/CN109031] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
6 Zhao L, Hu C, Cheng J, Zhang P, Jiang H, Chen J. Haemoglobin variability and all-cause mortality in haemodialysis patients: A systematic review and meta-analysis. Nephrology (Carlton) 2019;24:1265-72. [PMID: 30644618 DOI: 10.1111/nep.13560] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
7 Trevisan M, Clase CM, Evans M, Popov T, Ludvigsson JF, Sjölander A, Carrero JJ. Patterns of chronic and transient hyperkalaemia and clinically important outcomes in patients with chronic kidney disease. Clinical Kidney Journal 2022;15:153-61. [DOI: 10.1093/ckj/sfab159] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Chen Y, Fang W, Gu L, Cao L, Yan H, Huang J, Gu A, Mou S, Qian J, Ni Z. The role of hemoglobin variability as a prognostic indicator in peritoneal dialysis patients: a retrospective descriptive study. Int Urol Nephrol 2018;50:167-71. [PMID: 29094332 DOI: 10.1007/s11255-017-1722-8] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
9 Bucalo ML, Barbieri C, Roca S, Ion Titapiccolo J, Ros Romero MS, Ramos R, Albaladejo M, Manzano D, Mari F, Molina M. The anaemia control model: Does it help nephrologists in therapeutic decision-making in the management of anaemia? Nefrología (English Edition) 2018;38:491-502. [DOI: 10.1016/j.nefroe.2018.10.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
10 Rozen-Zvi B, Ben-Avraham B, Schneider S, Gafter-Gvili A, Levy-Drummer RS, Zingerman B, Mor E, Gafter U, Rahamimov R. Haemoglobin variability in the early post-transplant period: association with graft survival and mortality. Nephrology (Carlton) 2013;18:148-56. [PMID: 23134202 DOI: 10.1111/nep.12009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
11 Lin FJ, Zhang X, Huang LS, Ji G, Huang HD, Xie Y, Jiang GR, Zhou X, Lu W. Impact of hemoglobin variability on cardiovascular mortality in maintenance hemodialysis patients. Int Urol Nephrol 2018;50:1703-12. [PMID: 29974406 DOI: 10.1007/s11255-018-1919-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
12 Palaka E, Grandy S, van Haalen H, McEwan P, Darlington O. The Impact of CKD Anaemia on Patients: Incidence, Risk Factors, and Clinical Outcomes-A Systematic Literature Review. Int J Nephrol 2020;2020:7692376. [PMID: 32665863 DOI: 10.1155/2020/7692376] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
13 Wittbrodt ET, James G, Kumar S, van Haalen H, Chen H, Sloand JA, Kalantar-Zadeh K. Contemporary outcomes of anemia in US patients with chronic kidney disease. Clin Kidney J 2022;15:244-52. [PMID: 35145639 DOI: 10.1093/ckj/sfab195] [Reference Citation Analysis]
14 Nakazato Y, Sugiyama T, Ohno R, Shimoyama H, Leung DL, Cohen AA, Kurane R, Hirose S, Watanabe A, Shimoyama H. Estimation of homeostatic dysregulation and frailty using biomarker variability: a principal component analysis of hemodialysis patients. Sci Rep 2020;10:10314. [PMID: 32587279 DOI: 10.1038/s41598-020-66861-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
15 Gilbertson DT, Monda KL, Bradbury BD, Collins AJ. RBC Transfusions Among Hemodialysis Patients (1999-2010): Influence of Hemoglobin Concentrations Below 10 g/dL. American Journal of Kidney Diseases 2013;62:919-28. [DOI: 10.1053/j.ajkd.2013.05.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
16 Watschinger B, Salmhofer H, Horn S, Neyer U, Wiesinger T, Wiesholzer M, Erb H, Jaeger C, Hemetsberger M, Rosenkranz AR. The MAINTAIN study--managing hemoglobin variability with darbepoetin alfa in dialysis patients experiencing a severe drop in hemoglobin. Wien Klin Wochenschr 2013;125:71-82. [PMID: 23299452 DOI: 10.1007/s00508-012-0311-1] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
17 Bucalo ML, Barbieri C, Roca S, Ion Titapiccolo J, Ros Romero MS, Ramos R, Albaladejo M, Manzano D, Mari F, Molina M. The anaemia control model: Does it help nephrologists in therapeutic decision-making in the management of anaemia? Nefrologia (Engl Ed) 2018;38:491-502. [PMID: 29875061 DOI: 10.1016/j.nefro.2018.03.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
18 Kahlert J, Gribsholt SB, Gammelager H, Dekkers OM, Luta G. Control of confounding in the analysis phase - an overview for clinicians. Clin Epidemiol 2017;9:195-204. [PMID: 28408854 DOI: 10.2147/CLEP.S129886] [Cited by in Crossref: 30] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
19 Kim HJ, Park JI, Yoo KD, Kim Y, Baek H, Kim SH, Chang T, Kim HH, Lee KH, Hwang S, Kim CT, Koo H, Kim JH. Real-world treatment patterns of renal anemia in hemodialysis patients: A multicenter cohort study performed using DialysisNet (RRAHD study). Medicine (Baltimore) 2020;99:e18749. [PMID: 31914095 DOI: 10.1097/MD.0000000000018749] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
20 Altunoren O, Dogan E, Sayarlioglu H, Acar G, Yavuz YC, Aydın N, Sahin M, Akkoyun M, Isik IO, Altunoren O. Effect of hemoglobin variability on mortality and some cardiovascular parameters in hemodialysis patients. Ren Fail 2013;35:819-24. [PMID: 23751144 DOI: 10.3109/0886022X.2013.801270] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
21 Barbieri C, Bolzoni E, Mari F, Cattinelli I, Bellocchio F, Martin JD, Amato C, Stopper A, Gatti E, Macdougall IC, Stuard S, Canaud B. Performance of a Predictive Model for Long-Term Hemoglobin Response to Darbepoetin and Iron Administration in a Large Cohort of Hemodialysis Patients. PLoS One 2016;11:e0148938. [PMID: 26939055 DOI: 10.1371/journal.pone.0148938] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
22 Besarab A. Anemia and iron management. Semin Dial 2011;24:498-503. [PMID: 21906169 DOI: 10.1111/j.1525-139X.2011.00983.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
23 Sumida K, Diskin CD, Molnar MZ, Potukuchi PK, Thomas F, Lu JL, Rhee CM, Streja E, Yamagata K, Kalantar-Zadeh K, Kovesdy CP. Pre-End-Stage Renal Disease Hemoglobin Variability Predicts Post-End-Stage Renal Disease Mortality in Patients Transitioning to Dialysis. Am J Nephrol 2017;46:397-407. [PMID: 29130991 DOI: 10.1159/000484356] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
24 Pérez-Ruixo JJ, Cucala-Ramos M, García-Gonzalo E, Del Val Romero B, Valveny N. Between subjects variability in haemoglobin and dose are not associated with the erythropoiesis-stimulating agent used to treat anaemia in dialysis: a meta-analysis. Br J Clin Pharmacol 2013;75:15-25. [PMID: 22803621 DOI: 10.1111/j.1365-2125.2012.04383.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
25 Salgado Filho N, Lages JS, Brito DJA, Santos EJF, Dos Santos AM, de Souza FL, Mendes VGG, Silva GADS, Carneiro ECRL, Muniz MPR, Silva GEB, Sesso RCC. Variability in Hemoglobin Levels and the Factors Associated with Mortality in Hemodialysis Patients: A 78-Month Follow-Up Study. Int J Environ Res Public Health 2021;18:1078. [PMID: 33530448 DOI: 10.3390/ijerph18031078] [Reference Citation Analysis]